|
LifeCell Corporation - Company Profile Snapshot
| Company Profile: |
LifeCell Corporation |
| Ticker: |
LIFC |
| Exchanges: |
NAS |
| 2007 Sales: |
191,130,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Medical, Surgical & Dental Suppliers |
| Country: |
UNITED STATES |
| Employees: |
443 |
Business Description
LifeCell Corporation. The Company's principal activity is to develop and market biologically based solutions for the repair and replacement of damaged or inadequate human tissues in different clinical applications. The Company's patented tissue-processing technology produces a regenerative tissue matrix, which is a complex three-dimensional structure that contains vascular channels, proteins and growth factor-binding sites that provides a complete template for the regeneration of normal human tissue. The products of the Company include: AlloDerm for plastic reconstructive, burn and periodontal procedures; Cymetra for non-surgical correction of soft tissue defects; Repliform for urology and gynecology procedures; cryopreserved allograft skin for use as a temporary wound dressing in the treatment of burns; Cymetra, a version of AlloDerm in particulate form; Repliform for urogynecologic procedures; Graft Jacket for orthopedic applications and Allocratf DBM for bone grafting.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
